Neuroblastoma breakpoint family, member 22, pseudogene (NBPF22P)

Neuroblastoma breakpoint family, member 22, pseudogene (NBPF22P) is classified as a pseudogene in the human genome, indicating it does not code for a functional protein product. It is a member of the NBPF gene family, which contains both active genes and pseudogenes. NBPF22P specifically is known to contain only partial exonic structure (type 1 and type 13 exons) and lacks evidence of protein-coding capability. Pseudogenes typically do not serve as therapeutic targets or have direct biological or pathological roles, and there is no evidence NBPF22P serves as a drug target, biomarker, or has disease associations. NBPF22P should not be confused with protein-coding NBPF genes such as NBPF1, which have been investigated for their roles in cancer and as potential biomarkers. NBPF22P is a pseudogene and does not have such roles. If the intent was to reference a therapeutic or biologically functional NBPF family protein, a different, protein-coding NBPF member (e.g., NBPF1) should be selected. NBPF22P is a pseudogene, not a therapeutic or functional target. It has no known biological function, disease association, drug interaction, or targetable mechanism. Its inclusion in drug-target or biomarker databases is not appropriate.

Other names

MGC48637NBPF member 22, pseudogene